However, similarly to hereditary or somatic MPL (2) (38) as well as CALR mutations (35), impaired MPL cell-surface expression is a feature of JAK2 V617F-positive PV, ET, and PMF (44, 45). This evidence concerns the gene JAK2 and essential thrombocythemia.